Skip to main content
. 2015 Mar 27;350:h1567. doi: 10.1136/bmj.h1567

Table 2.

 Comorbidities among patients undergoing elective total hip and knee arthroplasties grouped by their receipt of perioperative fluid resuscitation with hydroxyethyl starch 6% or with albumin 5% or with neither. Values are numbers (percentages) of patients unless stated otherwise

Hydroxyethyl starch (n=43 732) Albumin (n=8022) Neither (n=999 687)
Median (IQR) Charlson comorbidity index 0 (0–1) 0 (0–1) 0 (0–1)
Elixhauser comorbidity grouping:
 Congestive heart failure 1660 (3.8) 444 (5.5) 29 922 (3.0)
 Valvular disease 2139 (4.9) 470 (5.9) 46 668 (4.7)
 Pulmonary circulation disease 498 (1.1) 143 (1.8) 11 908 (1.2)
 Peripheral vascular disease 1319 (3.0) 307 (3.8) 26 275 (2.6)
 Paralysis 158 (0.4) 49 (0.6) 3298 (0.3)
 Other neurological disorders 1966 (4.5) 403 (5.0) 40 601 (4.1)
 Chronic pulmonary disease 7164 (16.4) 1453 (18.1) 158 648 (15.9)
 Diabetes, no chronic complications 7743 (17.7) 1506 (18.8) 189 618 (19.0)
 Diabetes, chronic complications* 751 (1.7) 160 (2.0) 16 896 (1.7)
 Hypothyroidism 6704 (15.3) 1389 (17.3) 157 863 (15.8)
 Chronic renal failure 1813 (4.1) 527 (6.6) 42 356 (4.2)
 Hypertension, uncomplicated 27 400 (62.7) 4962 (61.9) 636 421 (63.7)
 Hypertension, complicated 2162 (4.9) 618 (7.7) 51 440 (5.1)
 Liver disease 468 (1.1) 135 (1.7) 10 500 (1.1)
 Chronic peptic ulcer disease* 30 (0.1) 4 (0.1) 496 (0.1)
 HIV/AIDS 29 (0.1) 12 (0.2) 515 (0.1)
 Lymphoma 177 (0.4) 44 (0.5) 3126 (0.3)
 Metastatic cancer 116 (0.3) 42 (0.5) 2161 (0.2)
 Solid tumor without metastasis 585 (1.3) 121 (1.5) 11 124 (1.1)
 Rheumatoid arthritis or collagen vascular disease 2115 (4.8) 471 (5.9) 47 774 (4.8)
 Coagulopathy 1249 (2.9) 363 (4.5) 25 301 (2.5)
 Obesity* 10 032 (22.9) 1806 (22.5) 225 086 (22.5)
 Weight loss 316 (0.7) 110 (1.4) 6634 (0.7)
 Fluid and electrolyte disorder 4586 (10.5) 1209 (15.1) 101 163 (10.1)
 Chronic blood loss anemia 1263 (2.9) 177 (2.2) 20 766 (2.1)
 Deficiency anemia 7421 (17.0) 1841 (22.9) 174 430 (17.4)
 Alcohol misuse 293 (0.7) 73 (0.9) 5410 (0.5)
 Drug misuse 197 (0.5) 58 (0.7) 6033 (0.6)
 Psychosis 970 (2.2) 204 (2.5) 20 136 (2.0)
 Depression 6614 (15.1) 1172 (14.6) 135 137 (13.5)
Other:
 Sleep apnea 5316 (12.2) 861 (10.7) 109 957 (11.0)

IQR=interquartile range.

χ2 test used to compare categorical variables, Kruskal-Wallis test for Charlson comorbidity index. All variables (except diabetes with chronic complications, chronic peptic ulcer disease, and obesity) were significantly associated with the type of fluid resuscitation; at least one of the comparisons between groups was significant (P<0.001).

*No significant differences between groups.